SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • 1
    WHO/UNAIDS. Emergency scale-up of antiretroviral therapy in resource-limited settings: Technical and operational recommendations to achieve 3 by 5. Geneva, Switzerland: World Health Organization; 2004. p 41.
  • 2
    Gottlieb MS,Schroff R,Schanker HM,Weisman JD,Fan PT,Wolf RA,Saxon A. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: Evidence of a new acquired cellular immunodeficiency. N Engl J Med 1981; 305: 14251431.
  • 3
    Taylor JM,Fahey JL,Detels R,Giorgi JV. CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: Which to choose and how to use. J Acquir Immune Defic Syndr 1989; 2: 114124.
  • 4
    Phillips AN,Lee CA,Elford J,Janossy G,Timms A,Bofill M,Kernoff PB. Serial CD4 lymphocyte counts and development of AIDS. Lancet 1991; 337: 389392.
  • 5
    Mandy F,Nicholson J,Autran B,Janossy G. T-cell subset counting and the fight against AIDS: Reflections over a 20-year struggle. Cytometry 2002; 50: 3945.
  • 6
    Mellors JW,Rinaldo CR,Jr,Gupta P,White RM,Todd JA,Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272: 11671170.
  • 7
    O'Shea S,Rostron T,Hamblin AS,Palmer SJ,Banatvala JE. Quantitation of HIV: Correlation with clinical, virological, and immunological status. J Med Virol 1991; 35: 6569.
  • 8
    O'Brien WA,Hartigan PM,Daar ES,Simberkoff MS,Hamilton JD. Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS. Ann Intern Med 1997; 126: 939945.
  • 9
    Harrigan R. Measuring viral load in the clinical setting. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10 ( Suppl 1): S34S40.
  • 10
    Miller V,Staszewski S,Sabin C,Carlebach A,Rottmann C,Weidmann E,Rabenau H,Hill A,Lepri AC,Phillips AN. CD4 lymphocyte count as a predictor of the duration of highly active antiretroviral therapy-induced suppression of human immunodeficiency virus load. J Infect Dis 1999; 180: 530533.
  • 11
    Hogg RS,Yip B,Chan KJ,Wood E,Craib KJ,O'Shaughnessy MV,Montaner JS. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA 2001; 286: 25682577.
  • 12
    Ledergerber B,Lundgren JD,Walker AS,Sabin C,Justice A,Reiss P,Mussini C,Wit F,d'Arminio MA,Weber R,Fusco G,Staszewski S,Law M,Hogg R,Lampe F,Gill MJ,Castelli F,Phillips AN. Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes. Lancet 2004; 364: 5162.
  • 13
    Cozzi LA,Phillips AN,d'Arminio MA,Castelli F,Antinori A,De Luca A,Pezzotti P,Alberici F,Cargnel A,Grima P,Piscopo R,Prestileo T,Scalise G,Vigevani M,Moroni M. When to start highly active antiretroviral therapy in chronically HIV-infected patients: Evidence from the ICONA study. AIDS 2001; 15: 983990.
  • 14
    Recommendations for zidovudine: Early infection. JAMA 1990; 263: 1606.
  • 15
    CDC. 1995 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. National Pediatric and Family HIV Resource Center and National Center for Infectious Diseases, Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 1995; 44: 111.
  • 16
    McAnulty JM,Modesitt SK,Yusem SH,Hyer CJ,Fleming DW. Improved AIDS surveillance through laboratory-initiated CD4 cell count reporting. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 16: 362366.
  • 17
    Shapiro HM,Perlmutter NG. ‘Killer’ applications: Towards affordable rapid cell-based diagnostics for malaria and tuberculosis. Cytometry Part B 2008; 74B ( Suppl. 1): in press. doi: 10.1002/cyto.b.20401 (this issue).
  • 18
    National Committee for Clinical Laboratory Standards. Clinical application of flow cytometry: Immunophenotyping of lymphocytes, approved guideline. Pennsylvania: NCCLS; 1998.
  • 19
    Brando B,Barnett D,Janossy G,Mandy F,Autran B,Rothe G,Scarpati B,D'Avanzo G,D'Hautcourt JL,Lenkei R,Schmitz G,Kunkl A,Chianese R,Papa S,Gratama JW. Cytofluorometric methods for assessing absolute numbers of cell subsets in blood. European Working Group on Clinical Cell Analysis. Cytometry 2000; 42: 327346.
  • 20
    Loken MR,Brosnan JM,Bach BA,Ault KA. Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry. Cytometry 1990; 11: 453459.
  • 21
    Mandy F,Bergeron M,Recktenwald D,Izaguirre CA. A simultaneous three-color T cell subsets analysis with single laser flow cytometers using T cell gating protocol. Comparison with conventional two- color immunophenotyping method. J Immunol Methods 1992; 156: 151162.
  • 22
    Janossy G,Jani I,Gohde W. Affordable CD4(+) T-cell counts on ‘single-platform’ flow cytometers I. Primary CD4 gating. Br J Haematol 2000; 111: 11981208.
  • 23
    Janossy G,Jani I,Kahan M,Barnett D,Mandy F,Shapiro H. Precise CD4 T-Cell counting using red diode laser excitation: For richer, for poorer. Cytometry 2002; 50: 7885.
  • 24
    Thomas RA,Krishan A,Robinson DM,Sams C,Costa F. NASA/American Cancer Society High-Resolution Flow Cytometry Project-I. Cytometry 2001; 43: 211.
  • 25
    Strauss K,Hannet I,Engels S,Shiba A,Ward DM,Ullery S,Jinguji MG,Valinsky J,Barnett D,Orfao A,Kestens L. Performance evaluation of the FACSCount System: A dedicated system for clinical cellular analysis. Cytometry 1996; 26: 5259.
  • 26
    Guava Technologies. The power of single cell analysis and counting through microcytometry. 2003. Available at www.guavatechnologies.com.
  • 27
    Mercolino TJ,Connelly MC,Meyer EJ,Knight MD,Parker JW,Stelzer GT,DeChirico G. Immunologic differentiation of absolute lymphocyte count with an integrated flow cytometric system: A new concept for absolute T cell subset determinations. Cytometry 1995; 22: 4859.
  • 28
    www.Partec.com/EssentialHealthCare HIV, AIDS, TB, malaria.
  • 29
    www.PointCare.net/pointcare NOWfor near-patient HIV monitoring.
  • 30
    Manian BS. Affordable diagnostics: Changing the paradigm in India. Cytometry Part B 2008; 74B( Suppl. 1): in press. DOI: 10.1002/cyto. b.20402 (this issue).
  • 31
    Faucher S,Martel A,Sherring A,Ding T,Malloch L,Kim JE,Bergeron M,Sandstrom P,Mandy FF. Protein bead array for the detection of HIV-1 antibodies from fresh plasma and dried-blood-spot specimens. Clin Chem 2004; 50: 12501253.
  • 32
    Jani IV,Janossy G,Brown DW,Mandy F. Multiplexed immunoassays by flow cytometry for diagnosis and surveillance of infectious diseases in resource-poor setting—Review. Lancet Infect Dis 2002; 2: 243250.
  • 33
    Meda N,Gautier-Charpentier L,Soudre RB,Dahourou H,Ouedraogo-Traore R,Ouangre A,Bambara A,Kpozehouen A,Sanou H,Valea D,Ky F,Cartoux M,Barin F,Van de PP. Serological diagnosis of human immuno-deficiency virus in Burkina Faso: Reliable, practical strategies using less expensive commercial test kits. Bull World Health Organ 1999; 77: 731739.
  • 34
    Faucher S,Martel A,Sherring A,Bogdanovic D,Malloch L,Kim JE,Bergeron M,Sandstrom P,Mandy FF. A combined HIV-1 protein bead array for serology assay and T-cell subset immunophenotyping with a hybrid flow cytometer: A step in the direction of a comprehensive multitasking instrument platform for infectious disease diagnosis and monitoring. Cytometry Part B 2006; 70B: 179188.
  • 35
    Janossy G,Jani IV,Brando B. New trends in affordable CD4 T-cell enumeration by flow cytometry in HIV/AIDS. Clin Appl Immunol Rev 2003; 4: 91107.
  • 36
    Sherman GG,Galpin JS,Patel JM,Mendelow BV,Glencross DK. CD4+ T cell enumeration in HIV infection with limited resources. J Immunol Methods 1999; 222: 209217.
  • 37
    Dieye TN,Vereecken C,Diallo AA,Ondoa P,Diaw PA,Camara M,Karam F,Mboup S,Kestens L. Absolute CD4 T-cell counting in resource-poor settings: Direct volumetric measurements versus bead-based clinical flow cytometry instruments. J Acquir Immune Defic Syndr 2005; 39: 3237.
  • 38
    Cassens U,Gohde W,Kuling G,Groning A,Schlenke P,Lehman LG,Traore Y,Servais J,Henin Y,Reichelt D,Greve B. Simplified volumetric flow cytometry allows feasible and accurate determination of CD4 T lymphocytes in immunodeficient patients worldwide. Antivir Ther 2004; 9: 395405.
  • 39
    Glencross D,Scott LE,Jani IV,Barnett D,Janossy G. CD45-assisted PanLeucogating for accurate, cost-effective dual-platform CD4+ T-cell enumeration. Cytometry 2002; 50: 6977.
  • 40
    Janossy G,Jani IV,Bradley NJ,Bikoue A,Pitfield T,Glencross DK. Affordable CD4(+)-T-cell counting by flow cytometry: CD45 gating for volumetric analysis. Clin Diagn Lab Immunol 2002; 9: 10851094.
  • 41
    Nicholson JK,Hubbard M,Jones BM. Use of CD45 fluorescence and side-scatter characteristics for gating lymphocytes when using the whole blood lysis procedure and flow cytometry. Cytometry 1996; 26: 1621.
  • 42
    Bergeron M,Nicholson JKA,Phaneuf S,Ding T,Soucy N,Badley A,Hawley-Foss NC,Mandy F. Selection of lymphocyte gating protocol has impact on the level of reliability of T-cell subsets in aging specimens. Cytometry 2002; 50: 5361.
  • 43
    Schnizlein-Bick CT,Mandy FF,O'Gorman MR,Paxton H,Nicholson JK,Hultin LE,Gelman RS,Wilkening CL,Livnat D. Use of CD45 gating in three and four-color flow cytometric immunophenotyping: Guideline from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry 2002; 50: 4652.
  • 44
    Mandy FF,Nicholson JK,McDougal JS. Guidelines for performing single-platform absolute CD4+ T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003; 52: 113.
  • 45
    Glencross DK,Janossy G,Coetzee LM,Lawrie D,Aggett HM,Scott LE,Sanne I,McIntyre J,Stevens W. Large-scale affordable panleucogated CD4 testing with proactive internal- and external quality assessment—in support of the South African National Comprehensive Care, Treatment, and Management Programme for HIV/AIDS. Cytometry Part B (Clin Cytometry) 2008; 74B ( Suppl. 1): in press. DOI: 10.1002/cyto.b.20384 (this issue).
  • 46
    Denny TN,Gelman R,Bergeron M,Forman M,Landay A,Louzao R,Mandy F,Schmitz J,Wilkening C,Glencross DK. A multi-laboratory study of CD4 counts using Flow Cytometric PanLeukogating (PLG): A NIAID-DAIDS Immunology Quality Assessment Program study. Cytometry Part B (Clin Cytometry) 2008; 74B ( Suppl 1): In press. DOI: 10.1002/cyto.b.20417.
  • 47
    Goddard GR,Sanders CK,Martin JC,Kaduchak G,Graves SW. Analytical performance of an ultrasonic particle focusing flow cytometer. Anal Chem 2007; 79: 87408746.
  • 48
    Lyamuya EF,Kagoma C,Mbena EC,Urassa WK,Pallangyo K,Mhalu FS,Biberfeld G. Evaluation of the FACScount, TRAx CD4 and Dynabeads methods for CD4 lymphocyte determination. J Immunol Methods 1996; 195: 103112.
  • 49
    Landay A,Ho JL,Hom D,Russell T,Zwerner R,Minuty JG,Kataaha P,Mmiro F,Jackson B. A rapid manual method for CD4+ T-cell quantitation for use in developing countries. AIDS 1993; 7: 15651568.
  • 50
    Didier JM,Kazatchkine MD,Demouchy C,Moat C,Diagbouga S,Sepulveda C,Di Lonardo AM,Weiss L. Comparative assessment of five alternative methods for CD4+ T-lymphocyte enumeration for implementation in developing countries. J Acquir Immune Defic Syndr 2001; 26: 193195.
  • 51
    Whitby L,Granger V,Storie I,Goodfellow K,Sawle A,Reilly JT,Barnett D. Quality control of CD4+ T-lymphocyte enumeration: Results from the last 9 years of the United Kingdom National External Quality Assessment Scheme for Immune Monitoring (1993–2001). Cytometry 2002; 50: 102110.
  • 52
    Bergeron M,Shafaie A,Ding T,Phaneuf S,Soucy N,Mandy F,Bradley J,Fahey J. Evaluation of stabilized blood cell products as candidate preparations for Quality Assessment Programs for CD4 T-Cell counting. Cytometry 2002; 50: 8691.
  • 53
    Mandy F,Bergeron M,Houle G,Bradley J,Fahey J. Impact of the international program for Quality Assessment and Standardization for Immunological Measures Relevant to HIV/AIDS: QASI. Cytometry 2002; 50: 111116.
  • 54
    Pattanapanyasat K,Shain H,Noulsri E,Lerdwana S,Thepthai C,Prasertsilpa V,Likanonsakul S,Yothipitak P,Nookhai S,Eksaengsri A. A multicenter evaluation of the PanLeucogating method and the use of generic monoclonal antibody reagents for CD4 enumeration in HIV-infected patients in Thailand. Cytometry Part B 2005; 65B: 2936.
  • 55
    Glencross DK,Aggett HM,Stevens WS,Bergeron M,Mandy F. African regional external quality assessment (AFREQAS) for CD4 T-cell enumeration: Development, outcomes, and performance of laboratories. Cytometry Part B 2008; 74B ( Suppl. 1): in press. doi: 10.1002/cyto.b.20397 (this issue).
  • 56
    Lynen L,Teav S,Vereecken C,De Munter P,An S,Jaques G,Kestens L. Validation of primary CD4 gating as an affordable strategy for absolute CD4 counting in Cambodia. J Acquir Immune Defic Syndr 2006; 43: 179185.
  • 57
    Varro R,Hoffman RA,Chen CH,Bui N. Evaluation of CD4 assay formats on the BD FACSArray Bioanalyser. Presented at the XV International AIDS Conference, Bangkok, Thailand. 2004. Abstract.
  • 58
    Ondoa P,Dieye TN,Vereecken C,Camara M,Diallo AA,Fransen K,Litzroth A,Mboup S,Kestens L. Evaluation of HIV-1 p24 antigenemia and level of CD8+CD38+ T cells as surrogate markers of HIV-1 RNA viral load in HIV-1-infected patients in Dakar, Senegal. J Acquir Immune Defic Syndr 2006; 41: 416424.
  • 59
    Glencross DK,Janossy G,Lawrie D,Coetzee L,Scott LE,Sanne I,McIntyre J,Stevens W. CD8/ CD38 activation yields important clinical information of effective anti-retroviral therapy (ART): Findings from the first year of the CIPRA-SA cohort. Cytometry Part B 2008; 74B ( Suppl. 1): in press. doi: 10.1002/cyto.b.20391 (this issue).
  • 60
    Patterson BK,Till M,Otto P,Goolsby C,Furtado MR,McBride LJ,Wolinsky SM. Detection of HIV-1 DNA and messenger RNA in individual cells by PCR-driven in situ hybridization and flow cytometry. Science 1993; 260: 976979.
  • 61
    Patterson BK,McCallister S,Schutz M,Siegel JN,Shults K,Flener Z,Landay A. Persistence of intracellular HIV-1 mRNA correlates with HIV-1-specific immune responses in infected subjects on stable HAART. AIDS 2001; 15: 16351641.
  • 62
    Scott LE,Stevens W,Lawrie D,Glencross D. The HIVRMI: A new affordable quantitative HIV monitoring tool. Presented at the XVI International AIDS Conference [MOPE0091]. Toronto, Canada 2006.
  • 63
    Goldmeyer J,Kong H,Tang W. Development of a novel one-tube isothermal reverse transcription thermophilic helicase-dependent amplification platform for rapid RNA detection. J Mol Diagn 2007; 9: 639644.
  • 64
    Tibbe AG,De Grooth BG,Greve J,Dolan GJ,Terstappen LW. Imaging technique implemented in CellTracks system. Cytometry 2002; 47: 248255.
  • 65
    Shapiro HM “Cellular astronomy”–a foreseeable future in cytometry. Cytometry Part A 2004; 60A: 115124.
  • 66
    Cheng X,Irimia D,Dixon M,Sekine K,Demirci U,Zamir L,Tompkins R,Rodriguez W,Toner M. A microfluidic device for practical label-free CD4+ T cell counting of HIV-infected subjects. Lab Chip 2007; 7: 170178.
  • 67
    MacLennan CA,Liu MKP,White S,van Oosterhout JJG,Simukonda F,Bwanali J,Moore MJ,Zijlstra EE,Drayson MT,Molyneux ME. Diagnostic accuracy and clinical utility of a simplified low cost method of counting CD4 cells with flow cytometry in Malawi: diagnostic accuracy study. BMJ 2007; 335: 190194.